Skip to content

An observational study to assess Pharmacist Awareness and Practices on Drug Safety in North Bengaluru India

Comparison of knowledge, attitude and practice of Pharmacovigilance and adverse drug reaction reporting among hospital pharmacist and community pharmacists in Bengaluru, India: A Cross sectional questionnaire-based study. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063228
Enrollment
250
Registered
2024-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Aditya V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The community and hospital pharmacist in North Bengaluru India who give their informed consent will be included in the study.

Exclusion criteria

Exclusion criteria: Participants who do not provide their consent will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The outcome will be measured using a suitable self-administered questionnaire designed by referring similar kinds of literatures with input from the experts using both open and closed ended questions and some modifications were made to the questionnaire which is used to compare the knowledge, attitude and practice of Pharmacovigilance and Adverse Drug Reaction reporting among hospital pharmacist and community pharmacists in North Bengaluru India.Timepoint: At baseline 4 weeks 8 weeks

Secondary

MeasureTime frame
The outcome will be measured using a suitable self-administered questionnaire designed by referring similar kinds of literatures with input from the experts using both open & closed ended questions & some modifications were made to the questionnaire which is used to evaluate knowledge, attitude, practice & future perspective on Pharmacovigilance & Adverse reaction reporting among hospital pharmacist & community pharmacists in North Bengaluru India.Timepoint: At baseline 2 weeks 6 weeks

Countries

India

Contacts

Public ContactSrilakshmi R Bhat

Gautham College of Pharamcy

adithyavh@gmail.com9008427619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026